Sign in
4

Changes in Ownership

BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-22-012272

Director sold 5,000 shares at $11.04 ($55,200)

  • Director acquired 5,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

ABERCROMBIE GEORGE B · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-04-18 Exercise or conversion : show line 1 in the form +5,000 $3.32 $16,600 5,000 D
2022-04-18 Sale : show line 2 in the form −5,000 $11.04 $55,200 0 D
Open-market sales · 5,000 sh · avg $11.04 · $55,200

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-04-18 Exercise or conversion : show line 3 in the form Automatic Stock Option Grant −5,000 0 D
Loading xslF345X03/form4.xml…